All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

BMS-986120

CAS number:1478712-37-6    molecular formula:C23H23N5O5S2

overview

compound introduction

BMS-986120 is a first-in-class oral and reversible protease-activated receptor 4 ( PAR4 ) antagonist, with IC 50 s of 9.5 nM and 2.1 nM in human and monkey blood, respectively. BMS-986120 has potent and selective antiplatelet effects In Vitro BMS-986120 has high binding affinity to PAR4 expressed on HEK293 cells and inhibition of PAR4-induced calcium mobilization with an IC 50 of 0.56 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo In monkeys, BMS (1 mg/kg) does not inhibit PA induced by PAR1-AP, ADP and collagen, supporting selectivity. BMS (0.2, 0.5, 1 mg/kg) reduces TW by 35±5, 49±4, and 83±4%, respectively. Maximum KBT and MBT increases are only 2.2-fold and 1.8-fold, respectively . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IC50: 9.5 nM (PAR4, human), 2.1 nM (PAR4, monkey)

Specs

Chinese alias-
English aliasHY-19837 | SCHEMBL15348871 | WDT28B7071 | BMS 986120 | BDBM176061 | 4-(4-{[(6-methoxy-2-{2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl}-1-benzofuran-4-yl)oxy]methyl}-5-methyl-1,3-thiazol-2-yl)morpholine | 1478712-37-6 | EX-A3977 | Imidazo(2,1-b)-1,3,4-thi
CAS number1478712-37-6molecular formulaC23H23N5O5S2
molecular weight513.59 g/molExact mass≥98%
PSA153.000 Ųlogp4.200

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS